- Lyophilization
- Freeze-drying — removing water from a peptide solution under vacuum to leave a stable, dry powder for long-term storage.
- Reconstitution
- Adding a liquid (diluent) back to a lyophilized powder to return it to solution form immediately before use.
- Diluent
- The specific liquid used to reconstitute a powder — commonly bacteriostatic water, sterile water, or an acidic solution, chosen based on the peptide's chemistry.
- Bacteriostatic water
- Sterile water containing a small amount of benzyl alcohol, which inhibits bacterial growth and allows a vial to be used over multiple doses.
- Benzyl alcohol
- A preservative added to bacteriostatic water that inhibits bacterial growth — a consideration for certain formulations and patient populations, which is why a pharmacist selects it deliberately.
- Excipient
- Any inactive ingredient included in a formulation (such as a preservative or stabilizer) alongside the active peptide.
- Isoelectric point (pI)
- The specific pH at which a peptide's positive and negative charges balance exactly, giving it a net charge of zero. Solubility typically drops sharply near the pI because the electrostatic repulsion that normally keeps molecules apart in solution disappears, making aggregation more likely.
- Deamidation
- A degradation reaction specific to asparagine and glutamine residues, in which the side chain reacts with the neighboring backbone to form a ring-shaped intermediate (a succinimide) that then opens back up — often into a subtly rearranged structure (isoaspartate) rather than the original one. Rate depends on pH, temperature, and where the residue sits in the peptide's structure.
- Co-solvent
- A secondary solvent — commonly DMSO, acetonitrile, or DMF in peptide chemistry — used alongside or instead of water to dissolve a peptide whose amino acid composition makes it poorly water-soluble on its own, typically because it's dominated by hydrophobic residues.
- Osmolality
- A measure of the total concentration of dissolved particles in a solution. Matters in peptide chemistry because a reconstituted solution's osmolality affects both the peptide's stability in solution and, for injectable use, compatibility with body tissue.
- Reconstitution ratio
- The relationship between the amount of lyophilized powder in a vial and the volume of diluent added to it, which together determine the resulting concentration of the reconstituted solution.
- Net charge
- The overall positive, negative, or neutral charge a peptide carries at a given pH, calculated from the balance of its acidic and basic amino acid residues. Net charge at pH 7 is the starting point technical solubility guides use to classify a peptide and recommend a diluent category.
- Chaotropic agent
- A substance (such as urea or guanidine hydrochloride) that disrupts the hydrogen bonding and hydrophobic interactions holding a peptide's structure together, sometimes used in small amounts to help dissolve difficult, highly hydrophobic sequences.
- Thiol
- The reactive sulfur-hydrogen (–SH) functional group on cysteine's side chain. Highly reactive toward oxygen, especially above neutral pH, which is why cysteine-containing peptides need special handling.
- Disulfide bond
- A sulfur-sulfur covalent bond formed when two cysteine thiols oxidize together. Can be a normal, intended part of a peptide's structure, or an unwanted degradation product when it forms between the wrong pair of cysteines or between separate peptide molecules.
- Succinimide intermediate
- A five-membered ring structure that forms transiently during deamidation, when an asparagine or glutamine side chain reacts with the adjacent backbone. Its later, non-uniform breakdown is what produces the structural drift characteristic of deamidation.
- Methionine sulfoxide
- An oxidized form of methionine, produced when atmospheric oxygen or reactive oxygen species react with methionine's sulfur atom. Further oxidation can convert it to methionine sulfone.
- Photooxidation
- Oxidative degradation triggered by absorbed light energy, concentrated at residues with light-absorbing ring structures (tryptophan and tyrosine in particular). Can continue reacting after the light source is removed, since the absorbed energy sets off a chain of subsequent chemical events.
- Freeze-thaw cycle
- One complete transition of a solution from frozen to liquid and back to frozen. Each cycle stresses a peptide mechanically and chemically, particularly at the ice-liquid interface as the solution refreezes, and repeated cycles are a well-documented aggregation risk.
- Turbidity
- Visible cloudiness or haziness in a solution, caused by particles (often peptide aggregates) scattering light. One of the standard visual signs used to judge whether a reconstituted solution has degraded.
- Visible particulates
- Undissolved, mobile particles (other than intentional gas bubbles) visible in a solution. Regulatory guidance on injectable products classifies them as inherent (from the formulation itself), intrinsic (from the container or manufacturing process), or extrinsic (outside contamination) — any of which is a reason not to use a solution.
- Sterile water for injection
- Water for injection with no preservative added. Chemically inert compared to bacteriostatic water, but because it contains nothing to inhibit microbial growth, it is generally treated as single-use once a vial has been punctured.
- Multi-dose vial
- A vial formulated (typically with a bacteriostatic preservative) to tolerate being punctured and drawn from more than once without discarding the remainder immediately.
- Aseptic technique
- Procedures used to prevent introducing microbial contamination while handling a sterile product — swabbing a vial top, using a new sterile needle and syringe, and minimizing exposure time, among other practices.
- USP <797>
- The United States Pharmacopeia's general chapter governing sterile compounding, including the risk-category framework (Category 1, 2, and 3) that determines the default beyond-use date ceiling a compounding pharmacy may assign to a compounded sterile preparation.
- Arrhenius equation / Q10 rule
- The chemistry describing how reaction rates, including degradation reactions, generally increase with temperature. A commonly cited approximation holds that rate roughly doubles for every 10°C rise — but this is explicitly a rule of thumb, not a universal law, and doesn't hold for every reaction or temperature range.
- Secondary structure
- The local folded shape (such as helices or sheets) a peptide chain's backbone forms through hydrogen bonding, distinct from its underlying amino acid sequence. Mechanical and chemical stress can disrupt secondary structure even without breaking any covalent bonds.
- Air-liquid interface
- The boundary between a liquid solution and the air above it. Many peptides are surface-active and partially unfold when they sit at this interface, which is why agitation — which continuously creates fresh interface — is a recognized aggregation risk.
- Extinction coefficient
- A measure of how strongly a substance absorbs light at a given wavelength. In peptide chemistry, the extinction coefficients of tryptophan and tyrosine at 280 nm are what make UV absorbance (A280) a standard way to estimate a peptide or protein's concentration in solution.
- Isomerization (isoAsp)
- A structural rearrangement — most notably aspartate converting to isoaspartate — that occurs as one of the common outcomes of nonenzymatic deamidation, altering the peptide backbone's geometry at that position without changing its overall amino acid identity.
- Trifluoroacetic acid (TFA)
- A strong acidic solvent sometimes used, like acetic acid, in small volumes to help dissolve basic peptides before dilution with water or buffer.
- Ammonium bicarbonate
- A mild basic buffer sometimes used in small volumes to help dissolve acidic peptides — whose acidic side chains become more soluble when deprotonated — before dilution.
- Cold-chain excursion
- A period during which a product being shipped or stored under cold-chain conditions is exposed to a temperature outside its intended range, potentially compromising stability even if the exposure was brief.
- Hygroscopic
- Prone to absorbing moisture from the surrounding air. Lyophilized peptide powder is generally hygroscopic, which is why containers are typically allowed to reach room temperature before opening (to avoid condensation) and resealed promptly.
- Denaturation
- The structural unfolding of a protein or peptide caused by heat, agitation, pH extremes, or other stress — often permanently reducing or eliminating its activity.
- Aggregation
- Peptide molecules clumping together in solution, typically triggered by agitation, temperature stress, or concentration issues — visible as cloudiness or particulate.
- Hydrolysis
- A chemical reaction in which water breaks the bonds holding a peptide chain together — one of the primary degradation pathways that occurs once a peptide is in solution.
- Oxidation
- A degradation reaction in which certain amino acid residues react with oxygen, altering the peptide's structure and often its activity — accelerated by heat and light.
- pH stability range
- The range of acidity or alkalinity within which a specific peptide remains structurally stable — outside that range, degradation and denaturation happen faster.
- Cold chain
- The unbroken sequence of proper refrigerated or frozen storage and transport conditions a product is kept within from manufacturing through end use.
- Beyond-use date
- The date assigned at the point of compounding or reconstitution reflecting a formulation-specific stability window — typically much sooner than the original manufacturer's expiration date on the unopened product.
- Potency assay
- A laboratory test that measures how much of a compound's active ingredient is actually present and functional, as opposed to simply confirming its identity.
- Research use only (RUO)
- A regulatory label indicating a compound is intended for laboratory research, not human use, and has not been evaluated by the FDA for safety, purity, or stability as a human drug product.
